Victory Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$876K Sell
2,418
-239
-9% -$81.8K 0.09% 151
2026
Q1
$935K Buy
2,657
+275
+12% +$98K 0.11% 127
2025
Q4
$780K Buy
2,382
+272
+13% +$86.3K 0.1% 140
2025
Q3
$595K Buy
2,110
+1,101
+109% +$319K 0.08% 133
2025
Q2
$282K Buy
+1,009
New +$286K 0.04% 174

Other funds holding AMGN

Victory Financial Group's AMGN Position: Q2 2026 in Review

Victory Financial Group reduced its Amgen (AMGN) stake by 9% in Q2 2026, selling an estimated $81.8K and leaving 2,418 shares worth $876K. The position accounts for 0.09% of the portfolio, ranked #151.

Victory Financial Group first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $935K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Victory Financial Group held 2,418 shares of Amgen worth $876K as of Q2 2026.
  • Victory Financial Group sold 239 Amgen shares in Q2 2026, an estimated $81.8K.
  • Amgen made up 0.09% of Victory Financial Group's portfolio in Q2 2026, its #151 holding.
  • Victory Financial Group first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • Victory Financial Group's Amgen position peaked at $935K in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Victory Financial Group's 13F filing for Q2 2026, filed 29 Jul 2026.